These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 16364831)
1. Warfarin therapy and systolic hypertension in men with atrial fibrillation. Krishnan S; Chawla N; Ezekowitz MD; Peixoto AJ Am J Hypertens; 2005 Dec; 18(12 Pt 1):1592-9. PubMed ID: 16364831 [TBL] [Abstract][Full Text] [Related]
2. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
3. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859 [TBL] [Abstract][Full Text] [Related]
4. Effect of hypertension on anticoagulated patients with atrial fibrillation. Lip GY; Frison L; Grind M; Eur Heart J; 2007 Mar; 28(6):752-9. PubMed ID: 17289744 [TBL] [Abstract][Full Text] [Related]
5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
6. Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up. Eveson DJ; Robinson TG; Potter JF Am J Hypertens; 2007 Mar; 20(3):270-7. PubMed ID: 17324738 [TBL] [Abstract][Full Text] [Related]
7. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH; Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203 [TBL] [Abstract][Full Text] [Related]
9. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577 [TBL] [Abstract][Full Text] [Related]
10. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
11. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210 [TBL] [Abstract][Full Text] [Related]
12. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
15. Stroke risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure. The Ohasama study. Inoue R; Ohkubo T; Kikuya M; Metoki H; Asayama K; Obara T; Hirose T; Hara A; Hoshi H; Hashimoto J; Totsune K; Satoh H; Kondo Y; Imai Y Am J Hypertens; 2007 Oct; 20(10):1125-31. PubMed ID: 17903698 [TBL] [Abstract][Full Text] [Related]
16. Effect of exercise on blood pressure in older persons: a randomized controlled trial. Stewart KJ; Bacher AC; Turner KL; Fleg JL; Hees PS; Shapiro EP; Tayback M; Ouyang P Arch Intern Med; 2005 Apr; 165(7):756-62. PubMed ID: 15824294 [TBL] [Abstract][Full Text] [Related]
17. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension. Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820 [TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone reduces office and diastolic ambulatory blood pressure following 1-year treatment in non-diabetic subjects with insulin resistance. Nilsson PM; Hedblad B; Donaldson J; Berglund G Blood Press; 2007; 16(2):95-100. PubMed ID: 17612907 [TBL] [Abstract][Full Text] [Related]
19. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]